Forecast of Global Artesunate Tablet 麻豆原创 Growth 2024

Publication ID:

PB24190014

Publication Date:

March 28, 2019

Pages:

134

Publisher:

MRRPB2

Countries:

Global [1]

USD 3,660.00

Pharma & Healthcare [2]

Healthcare [3]

Description:

Global Artesunate Tablet market will register a 7.1% CAGR in terms of revenue, the global market size will reach USD 180 million by 2024, from USD 130 million in 2019.

听

Forecast of Global Artesunate Tablet 麻豆原创 Growth 2024

听

Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinidine for severe malaria. Often it is used as part of combination therapy. It is not used for the prevention of malaria.

The classification of Artesunate Tablet includes Monoaromatic Artesunate and Compound Artesunate.

Artesunate Tablet is application in Hospital, Clinic and Other institution. The most of Artesunate Tablet is used in Hospital, and the market share of that is about 57 % in 2018.
Middle East and Africa is the largest consumption place, with a consumption market share nearly 78% in 2017.

听

According to this study, over the next five years the Artesunate Tablet market will register a 7.1% CAGR in terms of revenue, the global market size will reach US$ 180 million by 2024, from US$ 130 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Artesunate Tablet business, shared in Chapter 3.

听

This report presents a comprehensive overview, market shares, and growth opportunities of Artesunate Tablet market by product type, application, key manufacturers and key regions and countries.

听

This study considers the Artesunate Tablet value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Monoaromatic Artesunate
Compound Artesunate

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Clinic
Other

听

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

听

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Fosun Pharma (Guilin)
Ipca Laboratories
Sanofi Aventis
Ajanta Pharma
Shin Poong
Cipla
Acino
MCW Healthcare

听

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

听

Research objectives
To study and analyze the global Artesunate Tablet consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Artesunate Tablet market by identifying its various subsegments.
Focuses on the key global Artesunate Tablet manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Artesunate Tablet with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Artesunate Tablet submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hrs) post payment.

Table Of Contents:

Table of Contents

2019-2024 Global Artesunate Tablet Consumption 麻豆原创 Report

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 麻豆原创 Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Artesunate Tablet Consumption 2014-2024
2.1.2 Artesunate Tablet Consumption CAGR by Region
2.2 Artesunate Tablet Segment by Type
2.2.1 Monoaromatic Artesunate
2.2.2 Compound Artesunate
2.3 Artesunate Tablet Consumption by Type
2.3.1 Global Artesunate Tablet Consumption 麻豆原创 Share by Type (2014-2019)
2.3.2 Global Artesunate Tablet Revenue and 麻豆原创 Share by Type (2014-2019)
2.3.3 Global Artesunate Tablet Sale Price by Type (2014-2019)
2.4 Artesunate Tablet Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Artesunate Tablet Consumption by Application
2.5.1 Global Artesunate Tablet Consumption 麻豆原创 Share by Application (2014-2019)
2.5.2 Global Artesunate Tablet Value and 麻豆原创 Share by Application (2014-2019)
2.5.3 Global Artesunate Tablet Sale Price by Application (2014-2019)

3 Global Artesunate Tablet by Players
3.1 Global Artesunate Tablet Sales 麻豆原创 Share by Players
3.1.1 Global Artesunate Tablet Sales by Players (2017-2019)
3.1.2 Global Artesunate Tablet Sales 麻豆原创 Share by Players (2017-2019)
3.2 Global Artesunate Tablet Revenue 麻豆原创 Share by Players
3.2.1 Global Artesunate Tablet Revenue by Players (2017-2019)
3.2.2 Global Artesunate Tablet Revenue 麻豆原创 Share by Players (2017-2019)
3.3 Global Artesunate Tablet Sale Price by Players
3.4 Global Artesunate Tablet Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Artesunate Tablet Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Artesunate Tablet Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Artesunate Tablet by Regions
4.1 Artesunate Tablet by Regions
4.1.1 Global Artesunate Tablet Consumption by Regions
4.1.2 Global Artesunate Tablet Value by Regions
4.2 Americas Artesunate Tablet Consumption Growth
4.3 APAC Artesunate Tablet Consumption Growth
4.4 Europe Artesunate Tablet Consumption Growth
4.5 Middle East & Africa Artesunate Tablet Consumption Growth

5 Americas
5.1 Americas Artesunate Tablet Consumption by Countries
5.1.1 Americas Artesunate Tablet Consumption by Countries (2014-2019)
5.1.2 Americas Artesunate Tablet Value by Countries (2014-2019)
5.2 Americas Artesunate Tablet Consumption by Type
5.3 Americas Artesunate Tablet Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Artesunate Tablet Consumption by Countries
6.1.1 APAC Artesunate Tablet Consumption by Countries (2014-2019)
6.1.2 APAC Artesunate Tablet Value by Countries (2014-2019)
6.2 APAC Artesunate Tablet Consumption by Type
6.3 APAC Artesunate Tablet Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Artesunate Tablet by Countries
7.1.1 Europe Artesunate Tablet Consumption by Countries (2014-2019)
7.1.2 Europe Artesunate Tablet Value by Countries (2014-2019)
7.2 Europe Artesunate Tablet Consumption by Type
7.3 Europe Artesunate Tablet Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Artesunate Tablet by Countries
8.1.1 Middle East & Africa Artesunate Tablet Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Artesunate Tablet Value by Countries (2014-2019)
8.2 Middle East & Africa Artesunate Tablet Consumption by Type
8.3 Middle East & Africa Artesunate Tablet Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 麻豆原创 Challenges and Impact
9.3 麻豆原创 Trends

10 麻豆原创ing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Artesunate Tablet Distributors
10.3 Artesunate Tablet Customer

11 Global Artesunate Tablet 麻豆原创 Forecast
11.1 Global Artesunate Tablet Consumption Forecast (2019-2024)
11.2 Global Artesunate Tablet Forecast by Regions
11.2.1 Global Artesunate Tablet Forecast by Regions (2019-2024)
11.2.2 Global Artesunate Tablet Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States 麻豆原创 Forecast
11.3.2 Canada 麻豆原创 Forecast
11.3.3 Mexico 麻豆原创 Forecast
11.3.4 Brazil 麻豆原创 Forecast
11.4 APAC Forecast by Countries
11.4.1 China 麻豆原创 Forecast
11.4.2 Japan 麻豆原创 Forecast
11.4.3 Korea 麻豆原创 Forecast
11.4.4 Southeast Asia 麻豆原创 Forecast
11.4.5 India 麻豆原创 Forecast
11.4.6 Australia 麻豆原创 Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany 麻豆原创 Forecast
11.5.2 France 麻豆原创 Forecast
11.5.3 UK 麻豆原创 Forecast
11.5.4 Italy 麻豆原创 Forecast
11.5.5 Russia 麻豆原创 Forecast
11.5.6 Spain 麻豆原创 Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt 麻豆原创 Forecast
11.6.2 South Africa 麻豆原创 Forecast
11.6.3 Israel 麻豆原创 Forecast
11.6.4 Turkey 麻豆原创 Forecast
11.6.5 GCC Countries 麻豆原创 Forecast
11.7 Global Artesunate Tablet Forecast by Type
11.8 Global Artesunate Tablet Forecast by Application

12 Key Players Analysis
12.1 Fosun Pharma (Guilin)
12.1.1 Company Details
12.1.2 Artesunate Tablet Product Offered
12.1.3 Fosun Pharma (Guilin) Artesunate Tablet Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Fosun Pharma (Guilin) News
12.2 Ipca Laboratories
12.2.1 Company Details
12.2.2 Artesunate Tablet Product Offered
12.2.3 Ipca Laboratories Artesunate Tablet Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Ipca Laboratories News
12.3 Sanofi Aventis
12.3.1 Company Details
12.3.2 Artesunate Tablet Product Offered
12.3.3 Sanofi Aventis Artesunate Tablet Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Sanofi Aventis News
12.4 Ajanta Pharma
12.4.1 Company Details
12.4.2 Artesunate Tablet Product Offered
12.4.3 Ajanta Pharma Artesunate Tablet Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Ajanta Pharma News
12.5 Shin Poong
12.5.1 Company Details
12.5.2 Artesunate Tablet Product Offered
12.5.3 Shin Poong Artesunate Tablet Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Shin Poong News
12.6 Cipla
12.6.1 Company Details
12.6.2 Artesunate Tablet Product Offered
12.6.3 Cipla Artesunate Tablet Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Cipla News
12.7 Acino
12.7.1 Company Details
12.7.2 Artesunate Tablet Product Offered
12.7.3 Acino Artesunate Tablet Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Acino News
12.8 MCW Healthcare
12.8.1 Company Details
12.8.2 Artesunate Tablet Product Offered
12.8.3 MCW Healthcare Artesunate Tablet Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 MCW Healthcare News

13 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.